Revaprazan hydrochloride
98%
- Product Code: 103462
CAS:
178307-42-1
| Molecular Weight: | 398.91 g./mol | Molecular Formula: | C₂₂H₂₃FN₄HCl |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Revaprazan hydrochloride is primarily used as a potent and selective acid pump antagonist in the treatment of gastric acid-related disorders. It effectively inhibits the gastric H+/K+-ATPase enzyme, reducing acid secretion in the stomach. This makes it a valuable therapeutic option for managing conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis. Its rapid onset of action and prolonged efficacy provide significant relief from symptoms like heartburn and acid regurgitation. Additionally, it is often preferred for patients who may not respond adequately to proton pump inhibitors (PPIs) or require an alternative treatment option. Its role in promoting mucosal healing and preventing ulcer recurrence further underscores its clinical importance.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 5.000 | 10-20 days | $64.29 |
+
-
|
| 25.000 | 10-20 days | $224.01 |
+
-
|
| 100.000 | 10-20 days | $804.62 |
+
-
|
Revaprazan hydrochloride
Revaprazan hydrochloride is primarily used as a potent and selective acid pump antagonist in the treatment of gastric acid-related disorders. It effectively inhibits the gastric H+/K+-ATPase enzyme, reducing acid secretion in the stomach. This makes it a valuable therapeutic option for managing conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis. Its rapid onset of action and prolonged efficacy provide significant relief from symptoms like heartburn and acid regurgitation. Additionally, it is often preferred for patients who may not respond adequately to proton pump inhibitors (PPIs) or require an alternative treatment option. Its role in promoting mucosal healing and preventing ulcer recurrence further underscores its clinical importance.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :